5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The China Respiratory Devices Market is segmented by Type (Diagnostic and Monitoring Devices, Therapeutic Devices and Disposables)
The major factor broadly acting as a driving factor includes the high prevalence of respiratory diseases in China, the continuation of economic and demographic trends, technological advancements and increasing applications in-home care settings. In China, chronic respiratory diseases are the second leading cause of death. It is estimated that over 50% of Chinese men smoke, whereas smoking rates among women are lower in this country. Chronic obstructive pulmonary disease (COPD) is found to be widespread in China with almost 100 million people suffering from chronic lung disease according to a new Tulane University study published in 2018. The biggest preventable risk factors for the disease are cigarette smoking and air pollution and thus there are public-health priorities in China to reduce COPD-related diseases and deaths. Hence all these factors are expected to drive the overall market in China.
As per the scope of the report, respiratory devices refer to the supply of the respiratory gas mechanically to the patients with impaired respiratory function. The respiratory gas is usually enriched with oxygen and conveyed into the lung with a positive pressure generated by the device. The respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration.
Report scope can be customized per your requirements. Click here.
Spirometers help in diagnosing respiratory diseases, such as asthma, emphysema, bronchitis, and COPD. Furthermore, they can also be used to assess the shortness of breath, lung function before surgery, and the effect of medication.
The spirometers segment has been fueled by the recent technological advancements, in the field of spirometry that includes the development of small portable spirometers and the increasing accuracy, acceptability, and reproducibility of assessments with immediate feedback to the technician. Thus, the applications of spirometers make it easier for the patient to use this diagnostic device and is also increasingly adopted in hospitals and home care. Furthermore, China accounts for several small and mid-sized companies operating in the business of respiratory devices, where foreign products or brands from the United States, Germany, and Japan have a significant influence.
To understand key trends, Download Sample Report
Many companies are focusing on respiratory products across China. The companies are implementing certain strategic initiatives, such as a merger, new product launch, acquisition and partnerships that help them in strengthening their market position. For instance, in 2017, Drägerwerk AG & CO. KGAA introduced Oxylog VE300, a newly developed emergency and transport ventilator that is particularly apt for use outside of the hospital environment.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, and Asthma
4.2.2 Technological Advancements and Increasing Applications in Homecare Setting
4.3 Market Restraints
4.3.1 High Cost of Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 By Diagnostic and Monitoring Devices
188.8.131.52 Sleep Test Devices
184.108.40.206 Peak Flow Meters
220.127.116.11 Pulse Oximeters
18.104.22.168 Other Diagnostic and Monitoring Devices
5.1.2 By Therapeutic Devices
22.214.171.124 CPAP Devices
126.96.36.199 BiPAP Devices
188.8.131.52 Oxygen Concentrators
184.108.40.206 Other Therapeutic Devices
5.1.3 By Disposables
220.127.116.11 Breathing Circuits
18.104.22.168 Other Disposables
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 DeVilbiss Healthcare LLC
6.1.2 Dragerwerk AG
6.1.3 Fisher & Paykel Healthcare Ltd
6.1.4 GE Healthcare
6.1.5 GlaxoSmithKline PLC
6.1.6 Koninklijke Philips NV
6.1.7 Medtronic PLC
6.1.8 ResMed Inc.
6.1.9 Vincent Medical
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments